Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 145

1.

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).

Fabiani E, Calabrese C, Niscola P, Balleari E, Molteni A, Finelli C, Falconi G, Fenu S, Fianchi L, Criscuolo M, Salvi F, Lavorgna S, Buccisano F, Maurillo L, Lo Coco F, Cilloni D, Voso MT.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15655. [Epub ahead of print] No abstract available.

PMID:
30407614
2.

Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience.

Metafuni E, Criscuolo M, Spanu T, Sica S.

Ann Hematol. 2018 Nov 1. doi: 10.1007/s00277-018-3535-y. [Epub ahead of print] No abstract available.

PMID:
30387052
3.

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Lindfors Rossi EL, Finelli C, Cerqui E, Ottone T, Molteni A, Parma M, Santarone S, Candoni A, Sica S, Leone G, Lo-Coco F, Voso MT.

Leukemia. 2018 Oct 5. doi: 10.1038/s41375-018-0284-9. [Epub ahead of print] No abstract available.

PMID:
30291338
4.

Therapy-related myeloid neoplasms: clinical perspectives.

Fianchi L, Criscuolo M, Fabiani E, Falconi G, Maraglino AME, Voso MT, Pagano L.

Onco Targets Ther. 2018 Sep 17;11:5909-5915. doi: 10.2147/OTT.S101333. eCollection 2018. Review.

5.

Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes.

Gurnari C, Latagliata R, Buccisano F, Piciocchi A, Fenu S, Mancini S, Fianchi L, Criscuolo M, Sarlo C, Romano A, Falconi G, Niscola P, Di Veroli A, Breccia M, Piccioni A, Aloe-Spiriti MA, Lo-Coco F, Voso MT; GROM-L (Gruppo Romano-Laziale MDS); GROM-L (Gruppo Romano-Laziale MDS).

Leuk Res. 2018 Aug;71:89-91. doi: 10.1016/j.leukres.2018.07.002. Epub 2018 Jul 10. No abstract available.

PMID:
30029156
6.

SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.

Busca A, Cesaro S, Teofili L, Delia M, Cattaneo C, Criscuolo M, Marchesi F, Fracchiolla NS, Valentini CG, Farina F, Di Blasi R, Prezioso L, Spolzino A, Candoni A, Del Principe MI, Verga L, Nosari A, Aversa F, Pagano L; SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Expert Rev Hematol. 2018 Feb;11(2):155-168. doi: 10.1080/17474086.2018.1420472. Epub 2018 Jan 3.

PMID:
29285951
7.

Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome.

Criscuolo M, Fianchi L, Chiusolo P, Giammarco S, Bacigalupo A, Pagano L.

J Clin Immunol. 2018 Jan;38(1):7-9. doi: 10.1007/s10875-017-0467-6. Epub 2017 Dec 1. No abstract available.

PMID:
29196934
8.

Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.

Pagano L, Dragonetti G, Cattaneo C, Marchesi F, Veggia B, Busca A, Candoni A, Prezioso L, Criscuolo M, Cesaro S, Delia M, Fanci R, Stanzani M, Ferrari A, Martino B, Melillo L, Nadali G, Simonetti E, Ballanti S, Picardi M, Castagnola C, Decembrino N, Gazzola M, Fracchiolla NS, Mancini V, Nosari A, Principe MID, Aversa F, Tumbarello M; SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Haematologica. 2017 Oct;102(10):e407-e410. doi: 10.3324/haematol.2017.172536. Epub 2017 Jul 20. No abstract available.

9.

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

Mayer F, Faglioni L, Agabiti N, Fenu S, Buccisano F, Latagliata R, Ricci R, Spiriti MAA, Tatarelli C, Breccia M, Cimino G, Fianchi L, Criscuolo M, Gumenyuk S, Mancini S, Maurillo L, Nobile C, Niscola P, Piccioni AL, Tafuri A, Trapè G, Andriani A, De Fabritiis P, Voso MT, Davoli M, Zini G.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017046. doi: 10.4084/MJHID.2017.046. eCollection 2017.

10.

Treatment of Low-Blast Count AML using Hypomethylating Agents.

De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Review.

11.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S.

Ann Oncol. 2017 Jul 1;28(7):1547-1553. doi: 10.1093/annonc/mdx154.

PMID:
28368509
12.

Managing Formaldehyde indoor pollution in anatomy pathology departments.

d'Ettorre G, Criscuolo M, Mazzotta M.

Work. 2017;56(3):397-402. doi: 10.3233/WOR-172505. Review.

PMID:
28269801
13.

Clonal evolution in therapy-related neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, Hohaus S, Sica S, Postorino M, Neri A, Lionetti M, Leone G, Lo-Coco F, Voso MT.

Oncotarget. 2017 Feb 14;8(7):12031-12040. doi: 10.18632/oncotarget.14509.

14.

Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

Dragonetti G, Criscuolo M, Fianchi L, Pagano L.

Med Mycol. 2017 Jan 1;55(1):82-86. Epub 2016 Dec 2. Review.

PMID:
27915304
15.

Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.

Orlando L, Viale G, Bria E, Lutrino ES, Sperduti I, Carbognin L, Schiavone P, Quaranta A, Fedele P, Caliolo C, Calvani N, Criscuolo M, Cinieri S.

Breast. 2016 Dec;30:151-155. doi: 10.1016/j.breast.2016.09.015. Epub 2016 Oct 14.

PMID:
27750105
16.

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

Buccisano F, Piccioni AL, Nobile C, Criscuolo M, Niscola P, Tatarelli C, Fianchi L, Villivà N, Neri B, Carmosino I, Gumenyuk S, Mancini S, Voso MT, Maurillo L, Breccia M, Zini G, Venditti A, Fenu S, Spiriti MA, Latagliata R; GROM (Gruppo Romano Mielodisplasie).

Ann Hematol. 2016 Jun;95(7):1059-65. doi: 10.1007/s00277-016-2667-1. Epub 2016 Apr 19.

PMID:
27091349
17.

Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.

Criscuolo M, Fianchi L, Dragonetti G, Pagano L.

Expert Rev Hematol. 2016;9(2):197-208. doi: 10.1586/17474086.2016.1127156. Epub 2016 Jan 8. Review.

PMID:
26629730
18.

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G.

Exp Hematol. 2016 Jan;44(1):75-83.e1-4. doi: 10.1016/j.exphem.2015.10.005. Epub 2015 Oct 28.

PMID:
26521017
19.

Are adolescents with anorexia nervosa better at reading minds?

Laghi F, Pompili S, Zanna V, Castiglioni MC, Criscuolo M, Chianello I, Baumgartner E, Baiocco R.

Cogn Neuropsychiatry. 2015;20(6):489-501. doi: 10.1080/13546805.2015.1091766. Epub 2015 Oct 14.

PMID:
26465706
20.

How adolescents with anorexia nervosa and their parents perceive family functioning?

Laghi F, Pompili S, Zanna V, Castiglioni MC, Criscuolo M, Chianello I, Mazzoni S, Baiocco R.

J Health Psychol. 2017 Feb;22(2):197-207. doi: 10.1177/1359105315597055. Epub 2016 Jul 10.

PMID:
26253650

Supplemental Content

Loading ...
Support Center